NCT07783789Phase 2Not yet recruiting

NAI Plus Standard of Care Compared To SOC Alone Plus Standard of Care in Critically Ill Adults With Sepsis

Study sponsor: ImmunityBio, Inc. · IBRX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2028-05-12Estimated
Enrollment · participants50Estimated
Source updated2026-11-17Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: 28-day all-cause mortality rate Description: Proportion of participants who die from any cause by Day 28 after the first dose of study treatment. Time frame: From Day 1 (first NAI dose) through Day 28. After: Measure: 28-day all-cause mortality rate Description: Proportion of participants who die from any cause by Day 28 after the first dose of study treatment. Time frame: From Day 1 (first dose of study treatment) through Day 28.

Check registry source